Targeting of Stat3 activation may prove to be a more effective approach to controlling invasion than merely targeting individual molecules, such as VEGF and MMP-2, possibly representing a novel approach to regulating pancreatic cancer invasion. The gene discussed is MMP2; the disease is familial pancreatic carcinoma.